Change in the Board of Directors – Jaakko Eskola new Chair of the Board
CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 27 APRIL 2022 AT 1.40 PM EEST
Change in the Board of Directors – Jaakko Eskola new Chair of the Board
Cargotec Corporation’s Board of Directors elected by the Annual General Meeting has announced the appointment of Mr. Jaakko Eskola as the new Company Chair. Jaakko Eskola will succeed Mr. Ilkka Herlin who has chosen to step down as the Chair of the Board having served as Chair for 17 years since 2005. The change will take effect immediately. Ilkka Herlin will continue as a member of the board and as the Vice Chair.
Jaakko Eskola joined Cargotec’s Board in March 2021 after a distinguished career in Wärtsilä and was elected as vice chair of Cargotec’s Board of Directors previously in March 2022.
“It has been a privilege to be chair of this unique company. As we move into a new phase of the company I’m pleased to welcome Jaakko as my successor. I have strong confidence in Cargotec’s next wave of growth. Jaakko brings a wealth of industry and leadership experience across a wide range of companies that ideally equip him to help Cargotec navigate the transition into a more sustainable and profitable business that continues to generate substantial value for shareholders and customers,” says Ilkka Herlin.
“I’m very humbled and excited to accept the role as Chair of Cargotec, particularly at such an exceptional time for the industry and wider society. I’m honoured to succeed Ilkka and I look forward to working closely with the leadership to continue to ensure that Cargotec makes a positive impact for all stakeholders. I have already participated in the shaping of the refocused strategy that Cargotec has recently communicated and I’m convinced this is the right time to accelerate the transition to an even more profitable and futureproof business,” says Jaakko Eskola.
Ilkka Herlin will continue as a member of both the Audit and Risk Committee and Compensation and Nomination committee. Jaakko Eskola will chair the Compensation and Nomination committee.
As of today, Cargotec's Board of Directors consists of:
Jaakko Eskola, Chair
Ilkka Herlin, Vice Chair
Board of Directors
For further information, please contact:
Carina Geber-Teir, SVP Communications, tel. +358 40 5024 697
Cargotec (Nasdaq Helsinki: CGCBV) enables smarter cargo flow for a better everyday with its leading cargo handling solutions and services. Cargotec's business areas Kalmar, Hiab and MacGregor are pioneers in their fields. Through their unique position in ports, at sea and on roads, they optimise global cargo flows and create sustainable customer value. Cargotec has signed United Nations Global Compact Business Ambition for 1.5°C. The company's sales in 2021 totalled approximately EUR 3.3 billion and it employs around 11,000 people. www.cargotec.com
AttachmentsTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
RESULT OF RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS24.5.2022 11:30:00 CEST | Press release
AuctionAuction resultsAuction date2022-05-24Maturity2025Tendered volume, SEK mln500 +/- 500Offered volume, SEK mln994Volume bought, SEK mln0Number of bids4Number of accepted bids0 QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln34450000Volume bought, SEK mln0000Number of bids2100Number of accepted bids0000Average yield, %----Lowest accepted yield, %----Highest yield, %----Accepted at lowest yield, %---- QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln150000Volume bought, SEK mln0000Number of bids1000Number of accepted bids0000Average yield, %----Lowest accepted yield, %----Highest yield, %----Accepted at lowest yield, %----
Nexstim Receives an Order for Two NBS Systems from a Finnish University Hospital24.5.2022 11:30:00 CEST | Press release
Press release, Helsinki, 24 May 2022 at 12:30 PM (EEST) Nexstim Receives an Order for Two NBS Systems from a Finnish University Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has received an order for two NBS 5 systems from a university hospital in Finland. The customer is an experienced user of the Nexstim NBS 4 system, now acquiring the two new systems to replace the old system and to increase capacity. Nexstim’s NBS (Navigated Brain Stimulation) system is used, for example, in planning neurosurgery or radiation therapy after a patient has had a diagnosis of a brain tumor or other disorder. When the lesion is predicted to be close to functional areas of the brain—such as those responsible for speech production and limb movement —the brain maps generated with NBS can be invaluable when deciding the best, personalized treatment option for the patient. These specific NBS systems also include the software of an NBT® (Navigated Brain Therapy) system, allowing the sys
Sweegen Wins Stevia Reb M Patent Lawsuit Against PureCircle24.5.2022 11:04:00 CEST | Press release
Rancho Santa Margarita, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Sweegen, the global pioneer in wellness ingredient technologies and innovations, announced its victory against PureCircle in a stevia Rebaudioside M (Reb M) patent lawsuit. "Today's judgment vindicates Sweegen and affirms the company's position as an industry leader in innovative sweetener solutions," said Steven Chen, CEO of Sweegen. PureCircle, acquired by Ingredion in 2020, had filed the 2018 lawsuit against Sweegen in the U.S. District Court for the Central District of California, accusing Sweegen of infringing two PureCircle patents covering the manufacture of Reb M. The legal tide turned on PureCircle when Sweegen obtained a summary judgment that both of PureCircle's asserted patents are invalid. Since it is impossible to infringe an invalid patent, the court's invalidation of the asserted patents ends the infringement case against Sweegen at the U.S. District Court. "As a holder of core proprietary technologies of
Notification and Public Disclosure of Transactions by Person Discharging Managerial Responsibilities24.5.2022 11:00:00 CEST | Press release
Company Announcement No. 38/2022 Copenhagen, 24 May 2022 Notification and Public Disclosure of Transactions by Person Discharging Managerial Responsibilities 1. Information on the person discharging managerial responsibilities/person closely associated a) Name Anders Obel 2. Reason for the notification a) Position/title Member of the Board of Directors b) Initial notification/amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Scandinavian Tobacco Group A/S b) LEI code 5299003KG4JS99TRML67 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code Shares DK0060696300 – STG b) Nature of the transaction Sale of shares c) Price(s) and volume(s) Price(s)Volume(s)DKK 147.6 7,
Disclosure of voting rights for Chairman of the Board24.5.2022 10:44:47 CEST | Press release
Oslo, 24 May 2022. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual general meeting of the Company on 25 May 2022. Mr. Bøhn holds 123,662 shares, representing 0.3 per cent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 7,234,249 additional shares. In total, Mr. Bøhn will represent and vote for 19.7 per cent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of attorney are only valid at the annual general meeting on 25 May 2022. This information is subject to the disclosure requirements pursuant to section 4 -3, cf. section 5-12 of the Norwegian Securities Trading Act. Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CFO, email@example.com, Mobile: +47 9400 5757